Literature DB >> 25634425

Cardiovascular autonomic neuropathy (CAN) in patients of type 2 diabetes mellitus: a tertiary care hospital based study.

Zafar A Arif1, Imran Ali Shaikh2, Naila Masood3.   

Abstract

INTRODUCTION: Diabetes mellitus (DM) is a clinical syndrome characterized by hyperglycemia due to absolute or relative insulin deficiency. Cardiovascular autonomic neuropathy invokes potentially life threatening outcomes especially in poorly controlled diabetic patients. However, there is scarcity of epidemiological data for CAN in poorly controlled type 2 diabetic patients in Pakistan.
OBJECTIVE: The objective of this study is to assess the frequency of cardiovascular autonomic neuropathy (CAN) in patients with poorly controlled type 2 diabetes mellitus in Pakistan. STUDY
DESIGN: Descriptive cross-sectional.
SETTING: Department of Medicine, Liquate University Hospital, Hyderabad/Jamshoro, Sindh, Pakistan. DURATION: February to November 2012. SAMPLING TECHNIQUE: Non-probability purposive. MATERIAL AND
METHOD: This study included 207 patients, who all met the inclusion criteria and gave an informed consent for inclusion in the study. All the patients in the study were evaluated for CAN using four different clinical tests- Resting heart rate, test for orthostatic hypotension, hand gripping test and QTc interval on ECG. Resting Heart Rate of more than 100 beats per minute was taken as abnormal. Orthostatic hypotension was defined as a fall of systolic blood pressure >20 mmHg and/or diastolic blood pressure >10 mmHg on change of posture. The patients were asked to squeeze a small ball in hand gripping test and an increase in diastolic blood pressure <15 mmHg was considered abnormal. ECG recording with QTc interval >440 ms was considered abnormal or prolonged. Patients were labeled as CAN +ve if any two or more than two of the above listed tests were found positive/abnormal.
RESULTS: In our study, 76 out of 207 (36.7%) of the patients with poorly controlled type 2 diabetes mellitus were found to have cardiovascular autonomic neuropathy (CAN).
CONCLUSION: Cardiac autonomic dysfunctions are common in poorly controlled type 2 diabetes.
Copyright © 2014 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus type 2; Diabetic neuropathy; Epidemiology

Year:  2014        PMID: 25634425      PMCID: PMC4311000          DOI: 10.1016/j.ihj.2014.10.417

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  13 in total

1.  The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis.

Authors:  Raelene E Maser; Braxton D Mitchell; Aaron I Vinik; Roy Freeman
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

Review 2.  Stress testing in patients with diabetes mellitus: diagnostic and prognostic value.

Authors:  Anne R Albers; Marc Z Krichavsky; Gary J Balady
Journal:  Circulation       Date:  2006-01-31       Impact factor: 29.690

Review 3.  Diabetic cardiovascular autonomic neuropathy.

Authors:  Aaron I Vinik; Dan Ziegler
Journal:  Circulation       Date:  2007-01-23       Impact factor: 29.690

Review 4.  Diabetic neuropathies: a statement by the American Diabetes Association.

Authors:  Andrew J M Boulton; Arthur I Vinik; Joseph C Arezzo; Vera Bril; Eva L Feldman; Roy Freeman; Rayaz A Malik; Raelene E Maser; Jay M Sosenko; Dan Ziegler
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

5.  Autonomic neuropathy in nondiabetic offspring of type 2 diabetic subjects is associated with urinary albumin excretion rate and 24-h ambulatory blood pressure: the Fredericia Study.

Authors:  C H Foss; E Vestbo; A Frøland; H J Gjessing; C E Mogensen; E M Damsgaard
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

6.  Prediction of sudden cardiac death in diabetic autonomic neuropathy.

Authors:  J K Kahn; J C Sisson; A I Vinik
Journal:  J Nucl Med       Date:  1988-09       Impact factor: 10.057

7.  Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis.

Authors:  J M Pappachan; J Sebastian; B C Bino; K Jayaprakash; K Vijayakumar; P Sujathan; L A Adinegara
Journal:  Postgrad Med J       Date:  2008-04       Impact factor: 2.401

8.  Frequency of cardiac autonomic neuropathy in patients with type 2 diabetes mellitus reporting at a teaching hospital of Sindh.

Authors:  Haji Khan Khoharo; Fatima Qureshi
Journal:  J Coll Physicians Surg Pak       Date:  2008-12       Impact factor: 0.711

9.  Diabetic cardiac autonomic neuropathy in well-controlled diabetics within 1 year of diagnosis.

Authors:  Ali Jawa; Rizwan Bokhari; Ali Jawad; Javed Akram
Journal:  Indian J Endocrinol Metab       Date:  2011-07

10.  Identifying diabetic patients with cardiac autonomic neuropathy by heart rate complexity analysis.

Authors:  Ahsan H Khandoker; Herbert F Jelinek; Marimuthu Palaniswami
Journal:  Biomed Eng Online       Date:  2009-01-29       Impact factor: 2.819

View more
  2 in total

1.  Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy.

Authors:  Daniele Bosone; Alfredo Costa; Natascia Ghiotto; Matteo Cotta Ramusino; Annalisa Zoppi; Angela D'Angelo; Roberto Fogari
Journal:  Arch Med Sci       Date:  2016-09-22       Impact factor: 3.318

2.  Noninvasive exploration of Cardiac Autonomic Neuropathy by heart rate and blood pressure variability analysis in Type 2 Diabetic patients.

Authors:  Tallat Naz; Noor Un Nisa Memon; Kamran Afzal; Ambreen Shakir
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.